Diatech Pharmacogenetics Overview
- Founded
-
1996
- Status
-
Private
- Employees
-
60
- Latest Deal Type
-
PE Growth
- (Announced)
- Financing Rounds
-
2
- Investments
-
1
Diatech Pharmacogenetics General Information
Description
Developer of pharmacogenetics tests intended to identify gene mutations and genetic differences that are targets of personalized cancer therapies. The company offers services catering to the development, production and commercialization of molecular diagnostic tests for solid tumors, blood cancer and other infectious diseases, guiding diagnostic operators throughout the processes of sample extraction, quality control, molecular assay bioinformatic analysis and report, helping increase the effectiveness of cancer medicine through personalized diagnosis and treatments.
Contact Information
- Ignazio Silone, 1/B
- 60035 Jesi(Ancona)
- Italy
Diatech Pharmacogenetics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Diatech Pharmacogenetics Executive Team (6)
Diatech Pharmacogenetics Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
0000000 0000000 | Diatech Pharmacogenetics | Member of the Board of Statutory Auditors | 000 0000 |
00000000 000000000 | Diatech Pharmacogenetics | Board Member | 000 0000 |
Diatech Pharmacogenetics Signals
Diatech Pharmacogenetics Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Diatech Pharmacogenetics Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 | 07-Feb-2011 | 000000000 | IT Consulting and Outsourcing | 00000 000 |